Shin Nippon Biomedical Hits Day Low at JPY 1,250 Amid Price Pressure

Shin Nippon Biomedical Laboratories, a small-cap company in the miscellaneous industry, experienced significant volatility on May 11, 2026, with its stock price declining by 11.5%. The stock reached an intraday low of JPY 1,250.00, reflecting a challenging trading day. Over the past week, the stock has seen a decrease of 9.93%, while its performance over the last month shows a decline of 16.17%. Year-to-date, Shin Nippon Biomedical Laboratories has faced a notable drop of 24.04%, contrasting sharply with the Japan Nikkei 225, which has gained 23.99% during the same period. The company's financial metrics indicate a decline in operating profit by 21.87%, with net sales reported at JPY 6,429.09 million, marking a low point for the quarter. Additionally, the return on capital employed (ROCE) stands at 8.16%, and the inventory turnover ratio is at its lowest, at 1.01 times. These figures highlight the company's ongoing struggles in a competitive market environment.